NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Author:
Funder
National Eye Institute
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine
Reference80 articles.
1. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis;Tham;Ophthalmology,2014
2. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis;Quigley;Invest. Ophthalmol. Vis. Sci.,1995
3. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage;Libby;PLoS Genet.,2005
4. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma;Howell;J. Cell Biol.,2007
5. Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy;Nickells;Annu. Rev. Neurosci.,2012
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport;Molecular Neurodegeneration;2024-01-29
2. The concept of gene therapy for glaucoma;Neural Regeneration Research;2024-01
3. Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells;Biomedicine & Pharmacotherapy;2024-01
4. Genes as drugs for glaucoma: latest advances;Current Opinion in Ophthalmology;2023-12-21
5. The Role of Retinal Ganglion Cell Structure and Function in Glaucoma;Cells;2023-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3